"The marketable development for Wegovy and Ozempic is a must-win battle for [CEO] Mike Doustdar and the new board."Sren Lntoft HansenSydbank analyst President Donald Trump's second term in office has brought several headaches for pharmaceutical companies, Novo included
Depending on what else may be going on life stressors, vacation, change in routine sometimes patients may have no changes in weight or even regain despite medication therapy, she says
Graphical Abstract INTRODUCTION Peptide hormones, including leptin produced by the adipose tissue, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) produced by gastrointestinal tract, relay peripheral adiposity and nutritional signals to central nervous system to regulate feeding and glucose metabolism (1, 2)
Safer alternatives include optimising tirzepatide monotherapy with appropriate dose titration, structured NHS lifestyle programmes, licensed GLP-1 receptor agonists like semaglutide (Wegovy), or referral for bariatric surgery assessment
Because there is no generic alternative to this medication, it falls in the Preferred Brand category on drug formularies and is covered in a more expensive tier than generics or preferred generics. Regardless of the platform your health plan is built upon (fully insured, level-funded, or a true self-funded health plan) you likely have a formulary drug list that determines exactly how these drugs are covered as well as determining the costs for the member receiving the prescription
